← FDA Drug Approvals (Drugs@FDA)
SODIUM FLUORIDE F-18
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAMF · Approved 2022-12-06
Drug application
- FDA Application #
ANDA216126- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SODIUM FLUORIDE F-18
- Generic name
- Sodium Fluoride F-18
- Active ingredients
- SODIUM FLUORIDE F-18
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- BAMF
- First approval
- 2022-12-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown